Mounjaro (Tirzepatide), a groundbreaking GLP-1 receptor agonist targeting GIP receptors, is now available in India for ...

Eli Lilly launched its blockbuster diabetes and weight-loss drug Mounjaro in India on Thursday, beating rival Novo Nordisk ...

Amy Schumer’s experience with Mounjaro has been vastly different from when she tried an alternative weight-loss medication ...

Amy Schumer endorses the new weight loss drug Mounjaro, praising its effectiveness after an adverse experience with Wegovy.

Schumer said she was having success on Mounjaro after previously being unable to "handle" Ozempic's side effects.

Glucagon-like peptide-1 agonists, a class of medications known as GLP-1s, have grown in popularity, initially for the ...

The comedian shared in an Instagram video that she previously tried Wegovy three years ago but she "couldn't handle it" ...

Obesity remains a significant public health challenge in the UK, with over 26% of adults classified as obese and an ...

As research continues, Mounjaro may redefine medical weight loss strategies, but its ethical implications and long-term ...

Amy Schumer has opened up about her current health journey, revealing that she’s seeing strong results using the weight loss ...

Eli Lilly launches Mounjaro in India, targeting the $150B weight-loss market. The GLP-1 drug offers diabetes control & major ...

The global weight-loss drug market is expected to reach $150 billion in the next decade. By 2026, semaglutide (the active ...